HSCI and Stock Connect - Biotech Stocks Now Eligible; Inclusion & Exclusion Possibilities
Hang Seng Indexes Company (HSIL) reviews the constituents of the Hang Seng Composite Index (HSCI) on a half yearly basis in March and September...
771 Views
Kangji Medical IPO: Trading Debut
Kangji Medical (9997 HK) is the largest domestic minimally invasive surgical instruments and accessories (MISIA) platform in China, with a 2.7%...
403 Views
Kangji Medical IPO: Valuation Insights
Kangji Medical (1498779D CH) is the largest domestic minimally invasive surgical instruments and accessories (MISIA) platform in China, with a 2.7%...
360 Views
Venus Medtech Lock-Up Expiry: Could Face Selling Pressure
Venus Medtech is a dominant player in the heart valve replacement (TAVR) market in China and was listed in Hong Kong on December 10th. Since...
419 Views
Kangji Medical (康基医疗) Pre-IPO: COVID-19 Impacts and Thoughts on Valuation
Kangji Medical is a domestic leader in minimally invasive surgery devices. It has three main product types, trocars, polymer ligation clips, and...
519 Views